Rethinking the role of opioids in the outpatient management of chronic nonmalignant pain

References

• Institute of Medicine Committee on Advancing Pain Research, Care, and Education. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC: The National Academies Press (US), 2011
   Google Scholar
• US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. Health, United States, 2006: With Chartbook on Trends in the Health of Americans. Hyattsville, MD, 2006
   Google Scholar
• Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain 2012;13:715-24
   PubMed Web of Science ®Google Scholar
• Turk DC. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain 2002;18:355-65
   PubMed Web of Science ®Google Scholar
• Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002;287:337-44
   PubMed Web of Science ®Google Scholar
• Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain 2004;109:514-19
   PubMed Web of Science ®Google Scholar
• Thielke SM, Simoni-Wastila L, Edlund MJ, et al. Age and sex trends in long-term opioid use in two large American health systems between 2000 and 2005. Pain Med 2010;11:248-56
   PubMed Web of Science ®Google Scholar
• Wilson RD. Analgesic prescribing for musculoskeletal complaints in the ambulatory care setting after the introduction and withdrawal of cyclooxygenase-2 inhibitors. Arch Phys Med Rehab 2009;90:1147-51
   PubMed Web of Science ®Google Scholar
• Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf 2009;18:1166-75
   PubMed Web of Science ®Google Scholar
• Boscarino JA, Rukstalis MR, Hoffman SN, et al. Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria. J Addict Dis 2011;30:185-94
   PubMed Web of Science ®Google Scholar
• Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA 2013;309:657-9
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers – United States, 1999–2008. MMWR 2011;60:1487-92
   PubMedGoogle Scholar
• Moallem SA, Balali-Mood K, Balali-Mood M. In: Mozayani A, Raymon L, eds. Handbook of Drug Interactions Opioids and Opiates. New York, NY: Humana Press, 2012:159-91
   Google Scholar
• Alford DP, Liebschutz J, Chen IA, et al. Update in pain medicine. J Gen Intern Med 2008;23:841-5
   PubMed Web of Science ®Google Scholar
• Bollinger L. Under the Counter: The Diversion of Abuse of Controlled Prescription Drugs in the U.S. New York, NY: Columbia University, 2005
   Google Scholar
• American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 2009;57:1331-46
   PubMed Web of Science ®Google Scholar
• Deyo RA, Smith DHM, Johnson ES, et al. Opioids for back pain patients: primary care prescribing patterns and use of services. J Am Board Fam Med 2011;24:717-27
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Abdi S, Atluri S, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2 – guidance. Pain Phys 2012;15(3 Suppl):S67-116
   PubMed Web of Science ®Google Scholar
• Bates C, Laciak R, Southwick A, Bishoff J. Overprescription of postoperative narcotics: a look at postoperative pain medication delivery, consumption and disposal in urological practice. J Urol 2011;185:551-5
   PubMed Web of Science ®Google Scholar
• Joranson DE, Gilson AM, Dahl JL, Haddox JD. Pain management, controlled substances, and state medical board policy – a decade of change. J Pain Symptom Manag 2002;23:138-47
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Phys 2010;13:401-35
   PubMed Web of Science ®Google Scholar
• Phillips DM. JCAHO pain management standards are unveiled. Joint Commission on Accreditation of Healthcare Organizations. JAMA 2000;284:428-9
   PubMed Web of Science ®Google Scholar
• Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health 2009;99:221-7
   PubMed Web of Science ®Google Scholar
• Avouac J, Gossec L, Dougados M. Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 2007;15:957-65
   PubMed Web of Science ®Google Scholar
• Chou R, Ballantyne JC, Fanciullo GJ, et al. Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009;10:147-59
   PubMed Web of Science ®Google Scholar
• Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. Can Med Assoc J 2006;174:1589-94
   PubMed Web of Science ®Google Scholar
• Chu LF, Clark DJ, Angst MS. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J Pain 2006;7:43-8
   PubMed Web of Science ®Google Scholar
• Martin BC, Fan MY, Edlund MJ, et al. Long-term chronic opioid therapy discontinuation rates from the TROUP study. J Gen Intern Med 2011;26:1450-7
   PubMed Web of Science ®Google Scholar
• Conaghan PG, Dickson J, Grant RL, Guideline Development Group. Care and management of osteoarthritis in adults: summary of NICE guidance. BMJ 2008;336:502-3
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2012;64:455-74
   PubMed Web of Science ®Google Scholar
• Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005;64:669-81
   PubMed Web of Science ®Google Scholar
• Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16:137-62
   PubMed Web of Science ®Google Scholar
• Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010;18:476-99
   PubMed Web of Science ®Google Scholar
• American Academy of Orthopaedic Surgeons. Treatment of Osteoarthritis of the Knee (non-arthroplasy). Rosemont, IL: American Academy of Orthopaedic Surgeons, 2008
   Google Scholar
• , Coxib and traditional NSAID Trialists (CNT) CollaborationBhala N, Emberson J, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 2013;382:769-79
   PubMed Web of Science ®Google Scholar
• Dillon C, Paulose-Ram R, Hirsch R, Gu Q. Skeletal muscle relaxant use in the United States: data from the Third National Health and Nutrition Examination Survey (NHANES III). Spine 2004;29:892-6
   PubMed Web of Science ®Google Scholar
• Windmill J, Fisher E, Eccleston C, et al. Interventions for the reduction of prescribed opioid use in chronic non-cancer pain. Cochrane Database Syst Rev 2013;9:CD010323
   PubMed Web of Science ®Google Scholar
• Bhamb B, Brown D, Hariharan J, et al. Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin 2006;22:1859-65
   PubMed Web of Science ®Google Scholar
• Krenzelok EP, Royal MA. Confusion: acetaminophen dosing changes based on NO evidence in adults. Drugs R D 2012;12:45-8
   PubMedGoogle Scholar
• Towheed TE, Maxwell L, Judd MG, et al. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006;1:CD004257
   PubMed Web of Science ®Google Scholar
• Rao P, Knaus EE. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci 2008;11:81-110s
   PubMed Web of Science ®Google Scholar
• Carr DB, Goudas LC. Acute pain. Lancet 1999;353:2051-8
   PubMed Web of Science ®Google Scholar
• McGettigan P, Henry D. Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries. PLoS Med 2013;10:e1001388
   PubMed Web of Science ®Google Scholar
• Wolfe F, Zhao S, Lane N. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis Rheum 2000;43:378-85
   PubMed Web of Science ®Google Scholar
• Moore RA, Straube S, Wiffen PJ, et al. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev 2009;3:CD007076
   PubMed Web of Science ®Google Scholar
• Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2011;3:CD007938
   PubMed Web of Science ®Google Scholar
• Selph S, Carson S, Fu R, et al. Drug Class Review: Neuropathic Pain: Final Update 1 Report. Portland (OR): Oregon Health & Science University, 2011
   Google Scholar
• Parsons B, Tive L, Huang S. Gabapentin: a pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia. Am J Geriatr Phamacother 2004;2:157-62
   PubMedGoogle Scholar
• Pilowsky I, Hallett EC, Bassett DL, et al. A controlled study of amitriptyline in the treatment of chronic pain. Pain 1982;14:169-79
   PubMed Web of Science ®Google Scholar
• Chappell AS, Ossanna MJ, Liu-Seifert H, et al. Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. Pain 2009;146:253-60
   PubMed Web of Science ®Google Scholar
• Chappell AS, Desaiah D, Liu-Seifert H, et al. A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee. Pain Pract 2011;11:33-41
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Wohlreich M, Gaynor P, et al. Clinically relevant outcomes based on analysis of pooled data from 2 trials of duloxetine in patients with knee osteoarthritis. J Rheumatol 2012;39:352-8
   PubMed Web of Science ®Google Scholar
• Trindade E, Menon D, Topfer L-A, Coloma C. Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Can Med Assoc J 1998;159:1245-52
   PubMed Web of Science ®Google Scholar
• Vuppalanchi R, Hayashi PH, Chalasani N, et al. Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network. Aliment Pharmacol Ther 2010;32:1174-83
   PubMed Web of Science ®Google Scholar
• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005;352:1112-20
   PubMed Web of Science ®Google Scholar
• Kuehn BM. Serotonin syndrome update. JAMA 2011;306:2661
   Web of Science ®Google Scholar
• McNicol E, Horowicz-Mehler N, Fisk RA, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain 2003;4:231-56
   PubMed Web of Science ®Google Scholar
• Camí J, Farré M. Drug addiction. N Engl J Med 2003;349:975-86
   PubMed Web of Science ®Google Scholar
• Mogri M, Khan MI, Grant BJ, Mador MJ. Central sleep apnea induced by acute ingestion of opioids. Chest 2008;133:1484-8
   PubMed Web of Science ®Google Scholar
• Wang D, Teichtahl H, Drummer O, et al. Central sleep apnea in stable methadone maintenance treatment patients. Chest 2005;128:1348-56
   PubMed Web of Science ®Google Scholar
• Webster LR, Choi Y, Desai H, et al. Sleep-disordered breathing and chronic opioid therapy. Pain Med 2008;9:425-32
   PubMed Web of Science ®Google Scholar
• Walker JM, Farney RJ, Rhondeau SM, et al. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med 2007;3:455-61
   PubMed Web of Science ®Google Scholar
• Wang D, Teichtahl H. Opioids, sleep architecture and sleep-disordered breathing. Sleep Med Rev 2007;11:35-46
   PubMed Web of Science ®Google Scholar
• Moore JT, Kelz MB. Opiates, sleep, and pain: the adenosinergic link. Anesthesiology 2009;111:1175-6
   PubMed Web of Science ®Google Scholar
• Turk DC, Cohen MJ. Sleep as a marker in the effective management of chronic osteoarthritis pain with opioid analgesics. Semin Arthritis Rheum 2010;39:477-90
   PubMed Web of Science ®Google Scholar
• Carman WJ, Su S, Cook SF, et al. Coronary heart disease outcomes among chronic opioid and cyclooxygenase-2 users compared with a general population cohort. Pharmacoepidemiol Drug Saf 2011;20:754-62
   PubMed Web of Science ®Google Scholar
• Kalyani RR, Gavini S, Dobs AS. Male hypogonadism in systemic disease. Endocrinol Metab Clin North Am 2007;36:333-48
   PubMed Web of Science ®Google Scholar
• Daniell HW, Lentz R, Mazer NA. Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency. J Pain 2006;7:200-10
   PubMed Web of Science ®Google Scholar
• Smith HS, Elliott JA. Opioid-induced androgen deficiency (OPIAD). Pain Phys 2012;15(3 Suppl):ES145-56
   PubMed Web of Science ®Google Scholar
• Dublin S, Walker RL, Jackson ML, et al. Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case-control study. J Am Geriatr Soc 2011;59:1899-907
   PubMed Web of Science ®Google Scholar
• Bohnert AS, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011;305:1315-21
   PubMed Web of Science ®Google Scholar
• O’Neil CK, Hanlon JT, Marcum ZA. Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics. Am J Geriatr Pharmacother 2012;10:331-42
   PubMed Web of Science ®Google Scholar
• Younger JW, Chu LF, D’Arcy NT, et al. Prescription opioid analgesics rapidly change the human brain. Pain 2011;152:1803-10
   PubMed Web of Science ®Google Scholar
• Merrill JO, Von Korff M, Banta-Green CJ, et al. Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients. Gen Hosp Psychiatry 2012;34:581-7
   PubMed Web of Science ®Google Scholar
• Bohnert ASB, Ilgen MA, Ignacio RV, et al. Risk of death from accidental overdose associated with psychiatric and substance use disorders. Am J Psychiatry 2012;169:64-70
   PubMed Web of Science ®Google Scholar
• Gomes T, Mamdani MM, Dhalla IA, et al. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med 2011;171:686-91
   PubMed Web of Science ®Google Scholar
• Wasan AD, Davar G, Jamison R. The association between negative affect and opioid analgesia in patients with discogenic low back pain. Pain 2005;117:450-61
   PubMed Web of Science ®Google Scholar
• White JM, Irvine RJ. Mechanisms of fatal opioid overdose. Addiction 1999;94:961-72
   PubMed Web of Science ®Google Scholar
• Pattinson KTS. Opioids and the control of respiration. Brit J Anaesth 2008;100:747-58
   PubMed Web of Science ®Google Scholar
• Teichtahl H, Prodromidis A, Miller B, et al. Sleep-disordered breathing in stable methadone programme patients: a pilot study. Addiction 2001;96:395-403
   PubMed Web of Science ®Google Scholar
• Park JG, Ramar K, Olson EJ. Updates on definition, consequences, and management of obstructive sleep apnea. Mayo Clin Proc 2011;86:549-54
   PubMed Web of Science ®Google Scholar
• Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-89
   Google Scholar
• American Academy of Sleep Medicine. International classification of sleep disorders: diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine, 2005
   Google Scholar
• Dealberto MJ, Ferber C, Garma L, et al. Factors related to sleep apnea syndrome in sleep clinic patients. Chest 1994;105:1753-8
   PubMed Web of Science ®Google Scholar
• Wenk M, Pöpping D, Chapman G, et al. Long-term quality of sleep after remifentanil-based anaesthesia: a randomized controlled trial. Br J Anaesth 2013;110:250-7
   PubMed Web of Science ®Google Scholar
• Li L, Setoguchi S, Cabral H, Jick S. Opioid use for noncancer pain and risk of myocardial infarction amongst adults. J Intern Med 2013;273:511-26
   PubMed Web of Science ®Google Scholar
• Solomon DH, Rassen JA, Glynn RJ, et al. The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med 2010;170:1979-86
   PubMed Web of Science ®Google Scholar
• Swegle JM, Logemann C. Management of common opioid-induced adverse effects. Am Fam Phys 2006;74:1347-54
   PubMed Web of Science ®Google Scholar
• Flake ZA, Scalley RD, Bailey AG. Practical selection of antiemetics. Am Fam Phys 2004;69:1169-74
   PubMed Web of Science ®Google Scholar
• De Luca A, Coupar IM. Insights into opioid action in the intestinal tract. Pharmacol Ther 1996;69:103-15
   PubMed Web of Science ®Google Scholar
• Cook SF, Lanza L, Zhou X, et al. Gastrointestinal side effects in chronic opioid users: results from a population-based survey. Aliment Pharmacol Ther 2008;27:1224-32
   PubMed Web of Science ®Google Scholar
• Davies EC, Green CF, Mottram DR, Pirmohamed M. The use of opioids and laxatives, and incidence of constipation, in patients requiring neck-of-femur (NOF) surgery: a pilot study. J Clin Pharm Ther 2008;33:561-6
   PubMed Web of Science ®Google Scholar
• Bell TJ, Panchal SJ, Miaskowski C, et al. The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European patient survey (PROBE 1). Pain Med 2009;10:35-42
   PubMed Web of Science ®Google Scholar
• Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg 2001;182(5A Suppl):11-18S
   PubMed Web of Science ®Google Scholar
• Martin JL, Charboneau R, Barke RA, Roy S. Chronic morphine treatment inhibits LPS-induced angiogenesis: implications in wound healing. Cell Immunol 2010;265:139-45
   PubMed Web of Science ®Google Scholar
• Martin JL, Koodie L, Krishnan AG, et al. Chronic morphine administration delays wound healing by inhibiting immune cell recruitment to the wound site. Am J Pathol 2010;176:786-99
   PubMed Web of Science ®Google Scholar
• Ho WZ, Guo CJ, Yuan CS, et al. Methylnaltrexone antagonizes opioid-mediated enhancement of HIV infection of human blood mononuclear phagocytes. J Pharmacol Exp Ther 2003;307:1158-62
   PubMed Web of Science ®Google Scholar
• Martucci C, Panerai AE, Sacerdote P. Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses. Pain 2004;110:385-92
   PubMed Web of Science ®Google Scholar
• Mathew B, Lennon FE, Siegler J, et al. The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation. Anesth Analg 2011;112:558-67
   PubMed Web of Science ®Google Scholar
• Lennon FE, Moss J, Singleton PA. The μ-opioid receptor in cancer progression: is there a direct effect?. Anesthesiology 2012;116:940-5
   PubMed Web of Science ®Google Scholar
• Gupta K, Kshirsagar S, Chang L, et al. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 2002;62:4491-8
   PubMed Web of Science ®Google Scholar
• Bortsov AV, Millikan RC, Belfer I, et al. mu-Opioid receptor gene A118G polymorphism predicts survival in patients with breast cancer. Anesth 2012;116:896-902
   PubMed Web of Science ®Google Scholar
• Exadaktylos AK, Buggy DJ, Moriarty DC, et al. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesth 2006;105:660-4
   PubMed Web of Science ®Google Scholar
• Takkouche B, Montes-Martinez A, Gill SS, Etminan M. Psychotropic medications and the risk of fracture: a meta-analysis. Drug Saf 2007;30:171-84
   PubMed Web of Science ®Google Scholar
• Miller M, Sturmer T, Azrael D, et al. Opioid analgesics and the risk of fractures in older adults with arthritis. J Am Geriatr Soc 2011;59:430-8
   PubMed Web of Science ®Google Scholar
• French DD, Campbell R, Spehar A, et al. National outpatient medication profiling: medications associated with outpatient fractures in community-dwelling elderly veterans. Br J Clin Pharmacol 2007;63:238-44
   PubMed Web of Science ®Google Scholar
• Kamal-Bahl SJ, Stuart BC, Beers MH. Propoxyphene use and risk for hip fractures in older adults. Am J Geriatr Pharmacother 2006;4:219-26
   PubMedGoogle Scholar
• Gomes T, Redelmeier DA, Juurlink DN, et al. Opioid dose and risk of road trauma in Canada: a population-based study. JAMA Intern Med 2013;173:196-201
   PubMed Web of Science ®Google Scholar
• Gibson JE, Hubbard RB, Smith CJP, et al. Use of self-controlled analytical techniques to assess the association between use of prescription medications and the risk of motor vehicle crashes. Am J Epidemiol 2009;169:761-8
   PubMed Web of Science ®Google Scholar
• Engeland A, Skurtveit S, Mørland J. Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study. Ann Epidemiol 2007;17:597-602
   PubMed Web of Science ®Google Scholar
• Verster JC, Veldhuijzen DS, Volkerts ER. Effects of an opioid (oxycodone/paracetamol) and an NSAID (bromfenac) on driving ability, memory functioning, psychomotor performance, pupil size, and mood. Clin J Pain 2006;22:499-504
   PubMed Web of Science ®Google Scholar
• Zacny JP. A review of the effects of opioids on psychomotor and cognitive functioning in humans. Exp Clin Psychopharmacol 1995;3:432-466
   Web of Science ®Google Scholar
• Buckeridge D, Huang A, Hanley J, et al. Risk of injury associated with opioid use in older adults. J Am Geriatr Soc 2010;58:1664-70
   PubMed Web of Science ®Google Scholar
• Ashworth J, Green DJ, Dunn KM, Jordan KP. Opioid use among low back pain patients in primary care: is opioid prescription associated with disability at 6 month follow-up? Pain 2013;154:1038-44
   PubMed Web of Science ®Google Scholar
• Kidner CL, Mayer TG, Gatchel RJ. Higher opioid doses predict poorer functional outcome in patients with chronic disabling occupational musculoskeletal disorders. J Bone Joint Surg Am 2009;91:919-27
   PubMedGoogle Scholar
• Franklin GM, Stover BD, Turner JA, et al. Early opioid prescription and subsequent disability among workers with back injuries: the Disability Risk Identification Study Cohort. Spine 2008;33:199-204
   PubMed Web of Science ®Google Scholar
• Gross DP, Stephens B, Bhambhani Y, et al. Opioid prescriptions in Canadian workers’ compensation claimants: prescription trends and associations between early prescription and future recovery. Spine 2009;34:525-31
   PubMed Web of Science ®Google Scholar
• Webster BS, Verma SK, Gatchel RJ. Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use. Spine 2007;32:2127-32
   PubMed Web of Science ®Google Scholar
• Eriksen J, Sjogren P, Bruera E, et al. Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain 2006;125:172-9
   PubMed Web of Science ®Google Scholar
• Juratli SM, Mirza SK, Fulton-Kehoe D, et al. Mortality after lumbar fusion surgery. Spine 2009;34:740-7
   PubMed Web of Science ®Google Scholar
• Ordera G, Gan TJ, Johnson BH, Robinson SB. Effect of opioid-related adverse events on outcomes in selected surgical patients. J Pain Palliat Care Pharmacother 2013;27:62-70
   PubMedGoogle Scholar
• Alam A, Gomes T, Zheng H, et al. Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch Intern Med 2012;172:425-30
   PubMed Web of Science ®Google Scholar
• Carroll I, Barelka P, Wang CKM, et al. A pilot cohort study of the determinants of longitudinal opioid use after surgery. Anesth Analg 2012;115:694-702
   PubMed Web of Science ®Google Scholar
• Fitzgibbon DR, Posner KL, Domino KB, et al. Chronic pain management: American Society of Anesthesiologists Closed Claims Project. Anesthesiology 2004;100:98-105
   PubMed Web of Science ®Google Scholar
• Fitzgibbon DR, Rathmell JP, Michna E, et al. Malpractice claims associated with medication management for chronic pain. Anesthesiology 2010;112:948-56
   PubMed Web of Science ®Google Scholar
• The Management of Opioid Therapy for Chronic Pain Working Group. Departments of Veteran Affairs and Defense. Clinical Practice Guideline for Management of Opioid Therapy for Chronic Pain. Washington, DC: Departments of Veteran Affairs and Defense, 2010
   Google Scholar
• Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10:113-30
   PubMed Web of Science ®Google Scholar
• Savage SR. Assessment for addiction in pain-treatment settings. Clin J Pain 2002;18(4 Suppl):S28-38
   PubMed Web of Science ®Google Scholar
• Boscarino JA, Rukstalis M, Hoffman SN, et al. Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction 2010;105:1776-82
   PubMed Web of Science ®Google Scholar
• Højsted J, Sjøgren P. Addiction to opioids in chronic pain patients: a literature review. Eur J Pain 2007;11:490-518
   PubMed Web of Science ®Google Scholar
• Butler SF, Budman SH, Fernandez K, Jamison RN. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004;112:65-75
   PubMed Web of Science ®Google Scholar
• Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool. Pain Med 2005;6:432-42
   PubMed Web of Science ®Google Scholar
• Jamison RN, Clark JD. Opioid medication management: clinician beware! Anesthesiology 2010;112:777-8
   PubMed Web of Science ®Google Scholar
• Keskinbora K, Pekel AF, Aydinli I. Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: a randomized open trial. J Pain Symptom Manag 2007;34:183-9
   PubMed Web of Science ®Google Scholar
• Solanki DR, Koyyalagunta D, Shah RV, et al. Monitoring opioid adherence in chronic pain patients: assessment of risk of substance misuse. Pain Phys 2011;14:E119-31
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Whitfield E, Pallone F. Evolution of the National All Schedules Prescription Electronic Reporting Act (NASPER): a public law for balancing treatment of pain and drug abuse and diversion. Pain Phys 2005;8:335-47
   PubMedGoogle Scholar
• Fishman SM. Commentary in response to Paulozzi et al.: prescription drug abuse and safe pain management. Pharmacoepidemiol Drug Saf 2006;15:628-31
   PubMed Web of Science ®Google Scholar
• Christo PJ, Manchikanti L, Ruan X, et al. Urine drug testing in chronic pain. Pain Phys 2011;14:123-43
   PubMed Web of Science ®Google Scholar
• Starrels JL, Becker WC, Alford DP, et al. Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med 2010;152:712-20
   PubMed Web of Science ®Google Scholar
• Brater DC. Anti-inflammatory agents and renal function. Semin Arthritis Rheum 2002;32(3 Suppl 1):33-42
   PubMed Web of Science ®Google Scholar
• Mangoni AA, Woodman RJ, Gaganis P, et al. Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community. Br J Clin Pharmacol 2010;69:689-700
   PubMed Web of Science ®Google Scholar
• Andrew R, Derry S, Taylor RS, et al. The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain. Pain Practice 2014;14:79-94
   PubMed Web of Science ®Google Scholar
• Derry S, Moore RA, Rabbie R. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev 2012;9:CD007400
   PubMed Web of Science ®Google Scholar
• Gibofsky A, Silberstein S, Argoff C, et al. Lower-dose diclofenac submicron particle capsules provide early and sustained acute patient pain relief in a phase 3 study. Postgrad Med 2013;125:130-8
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Abdi S, Atluri S, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I – evidence assessment. Pain Phys 2012;15(3 Suppl):S1-65
   PubMed Web of Science ®Google Scholar
• Passik SD, Kirsh KL, Whitcomb L, et al. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther 2004;26:552-61
   PubMed Web of Science ®Google Scholar
• Cepeda MS, Camargo F, Zea C, Valencia L. Tramadol for osteoarthritis. Cochrane Database Syst Rev 2006;3:CD005522
   PubMedGoogle Scholar
• Emkey R, Rosenthal N, Wu S-C, CAPSS-114 Study Group. Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial. J Rheumatol 2004;31:150-6
   PubMed Web of Science ®Google Scholar
• Park K-S, Choi J-J, Kim W-U, et al. The efficacy of tramadol/acetaminophen combination tablets (Ultracet®) as add-on and maintenance therapy in knee osteoarthritis pain inadequately controlled by nonsteroidal anti-inflammatory drug (NSAID). Clin Rheumatol 2012;31:317-23
   PubMed Web of Science ®Google Scholar
• Rosenthal NR, Silverfield JC, Wu S-C, CAPSS-105 Study Group. Tramadol/acetaminophen combination tablets for the treatment of pain associated with osteoarthritis flare in an elderly patient population. J Am Geriatr Soc 2004;52:374-80
   PubMed Web of Science ®Google Scholar
• van Tulder MW, Touray T, Furlan AD, et al.; Cochrane Back Review Group. Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the Cochrane collaboration. Spine 2003;28:1978-92
   PubMed Web of Science ®Google Scholar
• Townsend CO, Kerkvliet JL, Bruce BK, et al. A longitudinal study of the efficacy of a comprehensive pain rehabilitation program with opioid withdrawal: comparison of treatment outcomes based on opioid use status at admission. Pain 2008;140:177-89
   PubMed Web of Science ®Google Scholar
• Chou R, Fanciullo GJ, Fine PG, et al. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009;10:131-46
   PubMed Web of Science ®Google Scholar